USOther

SAB Biotherapeutics Inc (SABSW)

US · Other

$0.02+40.59%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-18.9M
Profit YoY
-263.1%
EPS
$-0.12
EPS estimate
$0.00

Key statistics

P/E
0.1
Forward P/E
0.0
P/B
0.00
Book value
$3.00
EPS (TTM)
$0.29
52-week high
$0.06
52-week low
$0.00
50-day MA
$0.00
200-day MA
$0.00
Beta
0.53

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for SAB Biotherapeutics Inc — free to start.

Google PlayApp Store

Other Other companies

Data updated 2026-08-05.